
100% Water Soluble Curcumin Suppliers & Bulk Manufacturers
Available Forms: Capsules
Available Strengths: 500 mg, 1,000 mg
Reference Brands: Curcumin C3 Complex®, Theracurmin®, Meriva®(US); Curcumin Complex or Curcumin Phytosome.(EU)
Category: Oncology Cancer Care
100% Water Soluble Curcumin is available in Capsules and strengths such as 500 mg, 1,000 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, 100% Water Soluble Curcumin is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
Technical Specifications & Supply Details | |
---|---|
Lead Time | 7 to 60 days (depending on batch size & schedule) |
MOQ | As per manufacturer’s batch size |
COA | Available with every batch |
Regulatory Dossier / DMF | Available upon request |
Export Documentation | FSC, COA, Manufacturing License, Product Permission |
Standards | IP, BP, USP |
Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
100% Water Soluble Curcumin can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Product Description: 100% Water Soluble Curcumin is an innovative curcumin formulation designed for enhanced bioavailability and effective delivery. Used in oncology, it supports chemotherapy treatments, targets cancer cell proliferation, and promotes apoptosis. With its proven anti-inflammatory and antioxidant properties, it aids in reducing side effects during cancer treatment, including chemotherapy-induced nausea and fatigue. Available in capsules, tablets, softgels, liquid extracts, and powder forms, water-soluble curcumin is a promising adjunct therapy for patients in oncology. Available in the US and EU markets, it offers a comprehensive B2B opportunity for pharmaceutical manufacturers.
Frequently Asked Questions
Related Products
Atezolizumab
Strength: 1200 mg/20 mL
Form: Intravenous infusion
Reference Brands: Tecentriq® (EU & US)
View DetailsDurvalumab
Strength: 120 mg/4 mL, 500 mg/10 mL
Form: Injection
Reference Brands: Imfinzi® (US & EU)
View DetailsSunitinib
Strength: 12.5 mg, 25 mg, 37.5 mg, 50 mg
Form: Tablet
Reference Brands: Sutent® (EU & US)
View DetailsQuick Response Guaranteed | Verified Suppliers